STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNWV
  4. [Form 4] SANUWAVE Health, Inc. Insider Trading Activity

SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SANUWAVE Health, Inc. director Gregory Matthew Bazar received a grant of stock options as part of his compensation. He was awarded 5,524 options to buy Common Stock at an exercise price of $10.00 per share. The options were fully vested on the grant date and expire on June 30, 2031. Following this grant, he holds stock options for 5,524 underlying shares directly, with no shares reported as bought or sold in the market.

Positive

  • None.

Negative

  • None.
Insider Bazar Gregory Matthew
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 5,524 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 5,524 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 5,524 options Stock Option (right to buy) granted to director
Exercise price $10.00 per share Conversion or exercise price for the stock options
Underlying shares 5,524 shares Common Stock underlying the granted options
Total options after grant 5,524 options Total derivative holdings following the transaction
Option expiration date June 30, 2031 Expiration date of granted stock options
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 10.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bazar Gregory Matthew
(Last)(First)(Middle)
9600 W. 76TH STREET
SUITE 118
(Street)
EDEN PRAIRIE MINNESOTA 55344
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1006/30/2026A5,524 (1)06/30/2031Common Stock5,524$05,524D
Explanation of Responses:
1. Options were fully vested at the grant date.
/s/ Griffin D. Foster, Attorney-in-Fact for Gregory Bazar07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did SANUWAVE Health (SNWV) report for Gregory Matthew Bazar?

SANUWAVE Health reported that director Gregory Matthew Bazar received a grant of 5,524 stock options. These options give him the right to buy Common Stock at $10.00 per share and were fully vested on the grant date, expiring June 30, 2031.

Did Gregory Matthew Bazar buy or sell SANUWAVE Health (SNWV) shares in this Form 4?

No open-market buys or sells were reported. The Form 4 shows a compensation-related grant of 5,524 stock options with a $10.00 exercise price, fully vested at grant, giving him the right to acquire Common Stock in the future before June 30, 2031.

What are the key terms of Gregory Matthew Bazar’s stock options at SANUWAVE Health (SNWV)?

Bazar’s reported stock options cover 5,524 underlying shares of Common Stock at a $10.00 exercise price. The filing states the options were fully vested on the grant date and have an expiration date of June 30, 2031, if not exercised earlier.

How many SANUWAVE Health (SNWV) options does Gregory Matthew Bazar hold after this transaction?

After this transaction, Bazar holds stock options for 5,524 underlying shares directly. All of these options came from the reported grant, are fully vested, and are exercisable at $10.00 per share until their June 30, 2031 expiration date.

Is the SANUWAVE Health (SNWV) Form 4 transaction a routine compensation grant?

Yes. The Form 4 characterizes the event as a grant or award acquisition of 5,524 stock options, with a $10.00 exercise price and full vesting at grant. This reflects equity-based director compensation rather than a discretionary market purchase or sale.